{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T14:39:42Z","timestamp":1770475182138,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":8073,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1016\/s0301-472x(00)00142-9","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T22:34:39Z","timestamp":1027636479000},"page":"551-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["The tyrosine kinase inhibitor STI571, like interferon-\u03b1, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia"],"prefix":"10.1016","volume":"28","author":[{"given":"Stephen B","family":"Marley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.N","family":"Deininger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.John","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myrtle Y","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0301-472X(00)00142-9_BIB1","first-page":"10","article-title":"Cellular and molecular mechanisms in chronic myeloid leukaemia","volume":"95","author":"Gordon","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0950-3536(97)80015-7","article-title":"Treatment of chronic myeloid leukaemia","volume":"10","author":"Goldman","year":"1997","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB3","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood.V93.5.1534","article-title":"Autografting with Philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia","volume":"93","author":"Carella","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0950-3536(97)80009-1","article-title":"Interferon-\u03b1","volume":"10","author":"Richards","year":"1997","journal-title":"Baillieres Clin Haematol"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB5","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM198604243141701","article-title":"Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia","volume":"314","author":"Talpaz","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00001813-199404000-00013","article-title":"Tyrphostin-induced growth inhibition","volume":"5","author":"Kaur","year":"1994","journal-title":"Anticancer Drugs"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB7","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood.V82.12.3524.3524","article-title":"Tyrphostin-induced inhibition of p210bcr-abl tyrosine kinase activity induces K562 to differentiate","volume":"82","author":"Anafi","year":"1993","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB8","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.V80.5.1330.1330","article-title":"Effect of herbimycin A, an antagonist of tyrosine kinase, on bcr\/abl oncoprotein-associated cell proliferation","volume":"80","author":"Okabe","year":"1992","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB9","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of bcr-abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nature Med"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB10","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood.V90.9.3691","article-title":"The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells","volume":"90","author":"Deininger","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB11","unstructured":"Druker BJ, Sawyers CL, Talpaz M, Resta D, Peng B, Ford J (1999) Phase I trial of a specific ABL tyrosine kinase inhibitor, CGP 57148 in interferon refractory chronic myelogenous leukemia patients. Proc ASCO, 24 (abstr)."},{"key":"10.1016\/S0301-472X(00)00142-9_BIB12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1172\/JCI3094","article-title":"Treatment with interferon-\u03b1 preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM","volume":"102","author":"Gordon","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0002-9343(91)90536-7","article-title":"Circulating interferon-\u03b1 levels and hypertriglyceridemia in acquired immunodeficiency syndrome","volume":"90","author":"Grunfield","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB14","first-page":"765","article-title":"Radioimmunoassay of leukocyte (alpha) interferon and its application to some clinical conditions","volume":"25","author":"Bernier","year":"1984","journal-title":"J Nucl Med"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB15","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/jama.1982.03330190025025","article-title":"A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients","volume":"248","author":"Sherwin","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2249.1997.269-ce1161.x","article-title":"Effects of interferon-alpha (IFN-\u03b1) administration in healthy humans","volume":"107","author":"Corssmit","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB17","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.4049\/jimmunol.158.5.2390","article-title":"Activation of phosphatidylinositol 3-kinase serine kinase by IFN-alpha","volume":"158","author":"Uddin","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB18","doi-asserted-by":"crossref","first-page":"29991","DOI":"10.1074\/jbc.272.48.29991","article-title":"The type I interferon receptor mediates tyrosine phosphorylation of the Crkl adaptor protein","volume":"272","author":"Ahmed","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB19","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood.V94.7.2200.419a33_2200_2207","article-title":"BCR\/ABL mRNA and the p210BCR-ABL protein are downmodulated by interferon-a in chronic myeloid leukemia patients","volume":"94","author":"Pane","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0092-8674(94)90240-2","article-title":"The nuclear tyrosine kinase c-Abl negatively regulates cell growth","volume":"77","author":"Sawyers","year":"1994","journal-title":"Cell"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB21","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/21690","article-title":"The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage","volume":"399","author":"Gong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB22","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/21697","article-title":"Interaction of c-Abl and p73\u03b1 and their collaboration to induce apoptosis","volume":"399","author":"Agami","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB23","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/21704","article-title":"p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage","volume":"399","author":"Yuan","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB24","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0896-6273(00)80646-7","article-title":"Essential roles for Abl and Arg tyrosine kinases in neurulation","volume":"21","author":"Koleske","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB25","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0896-6273(00)81091-0","article-title":"The tyrosine kinase ABL and its substrate enabled collaborate with the receptor phosphatase Dlar to control motor axon guidance","volume":"22","author":"Wills","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/S0301-472X(00)00142-9_BIB26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0896-6273(00)81090-9","article-title":"Profilin and the Abl tyrosine kinase are required for motor axon outgrowth in the Drosophila embryo","volume":"22","author":"Wills","year":"1999","journal-title":"Neuron"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X00001429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X00001429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:12:05Z","timestamp":1759565525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X00001429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["S0301472X00001429"],"URL":"https:\/\/doi.org\/10.1016\/s0301-472x(00)00142-9","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The tyrosine kinase inhibitor STI571, like interferon-\u03b1, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0301-472X(00)00142-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}